- Home
- SWTX vs DEI Comparison
SWTX vs DEI Comparison
Compare SWTX & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWTX
- DEI
- Stock Information
- Founded
- SWTX 2017
- DEI 1971
- Country
- SWTX United States
- DEI United States
- Employees
- SWTX N/A
- DEI N/A
- Industry
- SWTX Biotechnology: Pharmaceutical Preparations
- DEI Real Estate Investment Trusts
- Sector
- SWTX Health Care
- DEI Real Estate
- Exchange
- SWTX Nasdaq
- DEI Nasdaq
- Market Cap
- SWTX 3.0B
- DEI 2.8B
- IPO Year
- SWTX 2019
- DEI 2006
- Fundamental
- Price
- SWTX $47.41
- DEI $16.09
- Analyst Decision
- SWTX Strong Buy
- DEI Buy
- Analyst Count
- SWTX 5
- DEI 9
- Target Price
- SWTX $72.40
- DEI $18.50
- AVG Volume (30 Days)
- SWTX 2.0M
- DEI 2.4M
- Earning Date
- SWTX 05-01-2025
- DEI 05-06-2025
- Dividend Yield
- SWTX N/A
- DEI 4.77%
- EPS Growth
- SWTX N/A
- DEI N/A
- EPS
- SWTX N/A
- DEI 0.13
- Revenue
- SWTX $191,589,000.00
- DEI $989,071,000.00
- Revenue This Year
- SWTX $85.98
- DEI N/A
- Revenue Next Year
- SWTX $69.16
- DEI N/A
- P/E Ratio
- SWTX N/A
- DEI $120.55
- Revenue Growth
- SWTX 3417.33
- DEI 0.46
- 52 Week Low
- SWTX $28.21
- DEI $12.50
- 52 Week High
- SWTX $62.00
- DEI $20.50
- Technical
- Relative Strength Index (RSI)
- SWTX 44.48
- DEI 44.89
- Support Level
- SWTX $45.88
- DEI $16.22
- Resistance Level
- SWTX $51.43
- DEI $16.71
- Average True Range (ATR)
- SWTX 2.12
- DEI 0.53
- MACD
- SWTX -0.66
- DEI 0.06
- Stochastic Oscillator
- SWTX 23.47
- DEI 48.03
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
About DEI Douglas Emmett Inc.
Douglas Emmett Inc is a real estate investment trust that acquires, develops, and manages office and multifamily properties in Los Angeles, California and Honolulu, Hawaii in the U.S. The company focuses on owning assets in communities with large supply constraints, such as the affluent neighborhoods of Los Angeles. The vast majority of Douglas Emmett's real estate portfolio is comprised of office buildings in Los Angeles. Most of these assets are located in the areas of Sherman Oaks, Woodland Hills, and Beverly Hills in terms of total square feet. Douglas Emmett derives nearly all of its income in the form of rental revenue from tenants. The vast majority of this also comes from its Los Angeles office buildings. The company's major tenants are legal, financial, and entertainment firms.